» Articles » PMID: 33792973

Most Men with Artificial Urinary Sphincter Cuff Erosion Have Low Serum Testosterone Levels

Overview
Date 2021 Apr 1
PMID 33792973
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To evaluate the relationship between serum testosterone (T) levels and artificial urinary sphincter (AUS) cuff erosion in a population of incontinent men who underwent AUS placement.

Methods: A retrospective analysis of our single-surgeon AUS database was performed to identify men with T levels within 24 months of AUS placement. Men were stratified into two groups based on serum testosterone: low serum testosterone (LT) (<280 ng/dl) and normal serum testosterone (NT) (>280 ng/dl). Multivariable analysis was performed to control for risk factors. The outcome of interest was the incidence of and time to spontaneous urethral cuff erosion; other risk factors for cuff erosion were also evaluated.

Results: Among 161 AUS patients with serum testosterone levels, 84 (52.2%) had LT (mean: 136.8 ng/dl, SD: 150.4 ng/dl) and 77 (47.8%) had NT (mean: 455.8 ng/dl, SD: 197.3 ng/dl). Cuff erosion was identified in 42 men (26.1%) at a median of 7.1 months postoperatively (interquartile range: 3.6-13.4 months), most of whom (30/42, 71.4%) were testosterone deficient. LT levels were less common (54/119, 45.4%) in the non-erosion cohort (p = 0.004). Men with low T were nearly three times as likely to suffer AUS erosion than men with normal T (odds ratio = 2.519, p = 0.021). LT level was the only factor associated with AUS erosion on multivariable analysis.

Conclusions: LT is an independent risk factor for AUS cuff erosion. Men with LT are more likely to present with cuff erosion, but there is no difference in time to erosion.

Citing Articles

Association Between Low Testosterone and Perioperative Outcomes in Patients Undergoing Transurethral Prostate Surgery.

Lin J, Panken E, Kumar S, Mi X, Schaeffer E, Brannigan R Cureus. 2024; 16(11):e74751.

PMID: 39735141 PMC: 11682848. DOI: 10.7759/cureus.74751.


Artificial urinary sphincter and stricture disease: surgical principles in management.

Martins F, Bernal J, Tryfonyuk L, Holm H Transl Androl Urol. 2024; 13(8):1717-1728.

PMID: 39280683 PMC: 11399027. DOI: 10.21037/tau-23-16.


The fragile urethra: what to do next?-a narrative review.

Pandit A, Chang C, Simhan J Transl Androl Urol. 2024; 13(8):1695-1708.

PMID: 39280657 PMC: 11399049. DOI: 10.21037/tau-22-798.


Artificial urinary sphincter erosion and infection: a contemporary review of perioperative considerations and management.

Desai T, Rozanski A Transl Androl Urol. 2024; 13(5):857-867.

PMID: 38855596 PMC: 11157387. DOI: 10.21037/tau-23-488.


Re: Camille Girard, Mehdi Al-Akri, Matthieu Durand, et al. Efficacy, Safety, and Reoperation-free Survival of Artificial Urinary Sphincter in Non-neurological Male Patients over 75 Years of Age. Eur Urol Open Sci 2023;53:23-30.

Perrin A, Singh J Eur Urol Open Sci. 2023; 58:8-9.

PMID: 37920241 PMC: 10618415. DOI: 10.1016/j.euros.2023.08.011.